Table 1.

Immunohistochemical analysis of phosphorylated STAT6 protein expression in lymphomas

Case no.
Diagnosis
Sex and age, y
Site
P-STAT6 staining
1   PMBL   F, 33   Med   ++  
2   PMBL   F, 57   Med   −  
3   PMBL   F, 40   Med   ++  
4   PMBL   M, 62   Med   −  
5   PMBL   F, 54   Med   ++  
6   PMBL   M, 27   Med   +  
7   PMBL   M, 66   Med   +  
8   PMBL   F, 23   Med   +  
9   PMBL   F, 37   Med   −  
10   PMBL   M, 23   Cervical LN*  ++  
11   PMBL   F, 50   Med   +  
12   DLBCL   F, 33   Axillary LN   −  
13   DLBCL   M, 78   Axillary LN   −  
14   DLBCL   F, 49   Inguinal LN   −  
15   DLBCL   M, 54   Cervical LN   −  
16   DLBCL   M, 60   Cervical LN   +  
17   DLBCL   M, 55   Cervical LN   −  
18   DLBCL   M, 70   Inguinal LN   −  
19   DLBCL   F, 68   Cervical LN   −  
20   DLBCL   M, 61   Inguinal LN   −  
21   DLBCL   F, 68   Axillary LN   −  
22   cHL, NS   F, 20   Cervical LN   +++  
23   cHL, NS   F, 22   Cervical LN   +++  
24   cHL, NS   F, 26   Cervical LN   +++  
25   cHL, NS   F, 40   Cervical LN   +++  
26
 		 cHL, NS
 		 F, 24
 		 Cervical LN
 		 −
 
Case no.
Diagnosis
Sex and age, y
Site
P-STAT6 staining
1   PMBL   F, 33   Med   ++  
2   PMBL   F, 57   Med   −  
3   PMBL   F, 40   Med   ++  
4   PMBL   M, 62   Med   −  
5   PMBL   F, 54   Med   ++  
6   PMBL   M, 27   Med   +  
7   PMBL   M, 66   Med   +  
8   PMBL   F, 23   Med   +  
9   PMBL   F, 37   Med   −  
10   PMBL   M, 23   Cervical LN*  ++  
11   PMBL   F, 50   Med   +  
12   DLBCL   F, 33   Axillary LN   −  
13   DLBCL   M, 78   Axillary LN   −  
14   DLBCL   F, 49   Inguinal LN   −  
15   DLBCL   M, 54   Cervical LN   −  
16   DLBCL   M, 60   Cervical LN   +  
17   DLBCL   M, 55   Cervical LN   −  
18   DLBCL   M, 70   Inguinal LN   −  
19   DLBCL   F, 68   Cervical LN   −  
20   DLBCL   M, 61   Inguinal LN   −  
21   DLBCL   F, 68   Axillary LN   −  
22   cHL, NS   F, 20   Cervical LN   +++  
23   cHL, NS   F, 22   Cervical LN   +++  
24   cHL, NS   F, 26   Cervical LN   +++  
25   cHL, NS   F, 40   Cervical LN   +++  
26
 		 cHL, NS
 		 F, 24
 		 Cervical LN
 		 −
 

PMBL indicates primary mediastinal B-cell lymphoma; F, female; med, mediastinum; M, male; LN, lymph node; DLBCL, nonmediastinal diffuse large B-cell lymphoma; and cHL, NS, classical Hodgkin lymphoma, nodular sclerosis type. ++ indicates 25% to 50% positive tumoral cells; +, 10% to 20% positive tumoral cells; and −, less than 10% positive tumoral cells.

*

Patient with bulky mediastinal mass.

View Large